{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:56:12Z","timestamp":1793318172143,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejim.2025.106612","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T04:40:01Z","timestamp":1764391201000},"page":"106612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Fractional exhaled nitric oxide in acute exacerbations of chronic obstructive pulmonary disease: A meta-analysis with meta-regressions"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-0428","authenticated-orcid":false,"given":"Pasquale","family":"Ambrosino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3336-7290","authenticated-orcid":false,"given":"Stefano Sanduzzi","family":"Zamparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9211-5523","authenticated-orcid":false,"given":"Giuseppina","family":"Marcuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7493-5954","authenticated-orcid":false,"given":"Fabio","family":"Manzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-8888","authenticated-orcid":false,"given":"Giorgio Alfredo","family":"Spedicato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4680-3058","authenticated-orcid":false,"given":"Christian","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-1408","authenticated-orcid":false,"given":"Costantino","family":"Mancusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-5328","authenticated-orcid":false,"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-6547","authenticated-orcid":false,"given":"Guido","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8643-658X","authenticated-orcid":false,"given":"Andrea","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Maniscalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.106612_bib0001","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00610-2019","article-title":"Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps","volume":"54","author":"Blanco","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2025.106612_bib0002","series-title":"Global initiative for chronic obstructive lung disease","year":"2025"},{"key":"10.1016\/j.ejim.2025.106612_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069679","article-title":"Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019","volume":"378","author":"Safiri","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2025.106612_bib0004","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-0915","article-title":"Identifying and treating COPD in cardiac patients","volume":"144","author":"Nozzoli","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2025.106612_bib0005","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037778","article-title":"Impact of pulmonary rehabilitation on patients with different chronic respiratory diseases during hospitalization","volume":"103","author":"Shi","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2025.106612_bib0006","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1164\/rccm.202306-1066ST","article-title":"Pulmonary rehabilitation for adults with Chronic Respiratory disease: an official American Thoracic Society clinical practice guideline","volume":"208","author":"Rochester","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0007","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1513\/AnnalsATS.202310-909CME","article-title":"Summary for clinicians: clinical practice guideline on pulmonary rehabilitation for adults with chronic Respiratory disease","volume":"21","author":"Jenkins","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ejim.2025.106612_bib0008","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00177-2024","article-title":"What every clinician should know about inflammation in COPD","volume":"10","author":"Wechsler","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.ejim.2025.106612_bib0009","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1183\/09059180.00008612","article-title":"Comorbidities of COPD","volume":"22","author":"Cavailles","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ejim.2025.106612_bib0010","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/rccm.202209-1748SO","article-title":"Phenotypes, etiotypes, and endotypes of exacerbations of chronic obstructive pulmonary disease","volume":"208","author":"Bhatt","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0011","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.niox.2011.03.079","article-title":"Nitrative stress in inflammatory lung diseases","volume":"25","author":"Sugiura","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejim.2025.106612_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9060614","article-title":"Clinical assessment of endothelial function in convalescent COVID-19 patients undergoing multidisciplinary pulmonary rehabilitation","volume":"9","author":"Ambrosino","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejim.2025.106612_bib0013","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0014","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S2213-2600(21)00170-3","article-title":"Increasing utility of FeNO as a biomarker of type-2 inflammation in severe asthma","volume":"9","author":"Chung","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S2213-2600(17)30424-1","article-title":"Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial","volume":"6","author":"Price","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0016","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S2213-2600(21)00124-7","article-title":"Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis","volume":"9","author":"Busse","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0017","series-title":"Global strategy for asthma management and prevention","year":"2025"},{"key":"10.1016\/j.ejim.2025.106612_bib0018","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/resp.14474","article-title":"Is FeNOtyping in COPD the path to precision medicine?","volume":"28","author":"Flynn","year":"2023","journal-title":"Respirology"},{"key":"10.1016\/j.ejim.2025.106612_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.10.026","article-title":"Biomarker-based asthma phenotypes of corticosteroid response","volume":"135","author":"Cowan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2025.106612_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00686-2023","article-title":"Exhaled nitric oxide, eosinophils and current smoking in COPD patients","volume":"9","author":"Higham","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.ejim.2025.106612_bib0021","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2025.106612_bib0022","first-page":"51","article-title":"Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD","author":"Alcazar-Navarrete","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2025.106612_bib0023","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/resp.14439","article-title":"Variability of fractional exhaled nitric oxide is associated with the risk and aetiology of COPD exacerbations","volume":"28","author":"Schumann","year":"2023","journal-title":"Respirology"},{"key":"10.1016\/j.ejim.2025.106612_bib0024","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/aac10a","article-title":"Central and peripheral airway nitric oxide in patients with stable and exacerbated chronic obstructive pulmonary disease","volume":"12","author":"Lazar","year":"2018","journal-title":"J Breath Res"},{"key":"10.1016\/j.ejim.2025.106612_bib0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12931-019-1133-8","article-title":"Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD","volume":"20","author":"Csoma","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.ejim.2025.106612_bib0026","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/ajrccm.157.3.97-05009","article-title":"Exhaled nitric oxide in chronic obstructive pulmonary disease","volume":"157","author":"Maziak","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0027","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2147\/COPD.S263673","article-title":"The value of FENO measurement for predicting treatment response in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"15","author":"Zhou","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.ejim.2025.106612_bib0028","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2147\/COPD.S257965","article-title":"Predictive value of exhaled nitric oxide and blood eosinophil count in the assessment of airway eosinophilia in COPD","volume":"15","author":"Antus","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.ejim.2025.106612_bib0029","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12890-021-01629-w","article-title":"Elevated levels of arginase activity are related to inflammation in patients with COPD exacerbation","volume":"21","author":"Rodriguez-Guzman","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0030","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.3760\/cma.j.issn.0366-6999.20123064","article-title":"Exhaled hydrogen sulfide in patients with chronic obstructive pulmonary disease and its correlation with exhaled nitric oxide","volume":"126","author":"Sun","year":"2013","journal-title":"Chin Med J"},{"key":"10.1016\/j.ejim.2025.106612_bib0031","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0032","unstructured":"National Heart, Lung, and Blood Institute (NHLBI) quality assessment tool. Available at https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools [Accessed 28 February 2025]."},{"key":"10.1016\/j.ejim.2025.106612_bib0033","article-title":"Effects of lifestyle interventions on weight amongst Pasifika communities: a systematic review and meta-analysis","volume":"25","author":"Palu","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ejim.2025.106612_bib0034","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejim.2025.106612_bib0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ejim.2025.106612_bib0036","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11065-019-09415-6","article-title":"A guide to conducting a meta-analysis with non-independent effect sizes","volume":"29","author":"Cheung","year":"2019","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.ejim.2025.106612_bib0037","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2025.106612_bib0038","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2025.106612_bib0039","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.ejim.2025.106612_bib0040","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s11135-017-0584-6","article-title":"Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour","volume":"52","author":"Johnston","year":"2018","journal-title":"Qual Quant"},{"key":"10.1016\/j.ejim.2025.106612_bib0041","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.2147\/COPD.S434040","article-title":"The relationship of fractional exhaled nitric oxide in patients with AECOPD","volume":"18","author":"Xu","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.ejim.2025.106612_bib0042","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s10753-013-9653-8","article-title":"Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide","volume":"36","author":"Soter","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.ejim.2025.106612_bib0043","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1183\/09031936.05.00047305","article-title":"Effects of exacerbations and seasonality on exhaled nitric oxide in COPD","volume":"26","author":"Bhowmik","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2025.106612_bib0044","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/15412555.2018.1482532","article-title":"Value of exhaled nitric oxide (FeNO) and eosinophilia during the exacerbations of chronic obstructive pulmonary disease requiring hospital admission","volume":"15","author":"Rio Ramirez","year":"2018","journal-title":"COPD"},{"key":"10.1016\/j.ejim.2025.106612_bib0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0046","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-030-78771-4_36","article-title":"Exhaled nitric oxide (FeNO) in patients hospitalized for an exacerbation of bronchiectasis and\/or COPD : feNO levels in COPD and bronchiectasis","volume":"1337","author":"Malli","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ejim.2025.106612_bib0047","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1440-1843.2010.01711.x","article-title":"Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations","volume":"15","author":"Antus","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.ejim.2025.106612_bib0048","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5603\/ARM.28143","article-title":"The effect of asthma and COPD exacerbation on exhaled nitric oxide (FE(NO))]","volume":"72","author":"Maskey-Warzechowska","year":"2004","journal-title":"Pneumonol Alergol Pol"},{"key":"10.1016\/j.ejim.2025.106612_bib0049","doi-asserted-by":"crossref","first-page":"249","DOI":"10.15537\/1658-3175.1391","article-title":"Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia","volume":"22","author":"Al-Ali","year":"2001","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ejim.2025.106612_bib0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1034\/j.1399-3003.1999.14c08.x","article-title":"Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease","volume":"14","author":"Agusti","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2025.106612_bib0051","first-page":"365","article-title":"Fractional exhaled nitric oxide in bronchial inflammatory lung diseases","volume":"39","author":"Xia","year":"2014","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ejim.2025.106612_bib0052","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/IJGM.S284688","article-title":"Clinical utility of Central and peripheral airway nitric oxide in aging patients with stable and acute exacerbated chronic obstructive pulmonary disease","volume":"14","author":"Fan","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0053","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/15412555.2018.1535581","article-title":"Monitoring antioxidant enzyme activity during exacerbations of chronic obstructive pulmonary disease","volume":"15","author":"Antus","year":"2018","journal-title":"COPD"},{"key":"10.1016\/j.ejim.2025.106612_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/cells12212518","article-title":"Exhaled nitric oxide as biomarker of type 2 diseases","volume":"12","author":"Maniscalco","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejim.2025.106612_bib0055","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/ab0167","article-title":"Comparison of three different exhaled nitric oxide analyzers in chronic respiratory disorders","volume":"13","author":"Molino","year":"2019","journal-title":"J Breath Res"},{"key":"10.1016\/j.ejim.2025.106612_bib0056","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.106612_bib0057","first-page":"14","article-title":"Endotyping chronic Respiratory diseases: T2 inflammation in the United Airways model","author":"Ambrosino","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.ejim.2025.106612_bib0058","first-page":"63","article-title":"ERS technical standard: global Lung Function Initiative reference values for exhaled nitric oxide fraction (F (ENO(50)) )","author":"Hogman","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2025.106612_bib0059","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(22)01273-9","article-title":"Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission","volume":"400","author":"Stolz","year":"2022","journal-title":"Lancet."},{"key":"10.1016\/j.ejim.2025.106612_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12111906","article-title":"Fractional exhaled nitric oxide (FeNO) in patients with stable chronic obstructive pulmonary disease: short-term variability and potential clinical implications","volume":"12","author":"Ambrosino","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0061","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/thoraxjnl-2016-209023","article-title":"A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD","volume":"72","author":"Wilkinson","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.ejim.2025.106612_bib0062","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2022.07.003","article-title":"TSLP, IL-33, and IL-25: not just for allergy and helminth infection","volume":"150","author":"Stanbery","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2025.106612_bib0063","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-2600(24)00299-6","article-title":"Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial","volume":"13","author":"Ramakrishnan","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0064","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211070139","article-title":"The long-term clinical impact of COPD exacerbations: a 3-year observational study (SHERLOCK)","volume":"16","author":"Haughney","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ejim.2025.106612_bib0065","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2019.02.025","article-title":"A prospective cohort study on the effects of geriatric rehabilitation following acute exacerbations of COPD","volume":"20","author":"van Dam van Isselt","year":"2019","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.ejim.2025.106612_bib0067","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.rmed.2018.06.027","article-title":"Including changes in dyspnea after inpatient rehabilitation improves prediction models of exacerbations in COPD","volume":"141","author":"Schuler","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0068","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12890-018-0718-1","article-title":"Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis","volume":"18","author":"Ryrso","year":"2018","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ejim.2025.106612_bib0069","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.chest.2018.01.054","article-title":"Pulmonary rehabilitation, exercise, and exacerbations of COPD: known clinical efficacy and the unknown mechanisms","volume":"153","author":"Jenkins","year":"2018","journal-title":"Chest"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525004893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525004893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:26:59Z","timestamp":1785205619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525004893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":69,"alternative-id":["S0953620525004893"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106612","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fractional exhaled nitric oxide in acute exacerbations of chronic obstructive pulmonary disease: A meta-analysis with meta-regressions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106612"}}